Anthony Letai
Physician · Dana-Farber Cancer Institute
Credentials: · · ·
History
- 2019–Present
- 1998–2001
Hematology and Medical Oncology
- 1995–1998
Internal Medicine
University Chicago
- 1991–1995
Doctor of Medicine
Research
The landscape of somatic copy-number alteration across human cancers
Nature · 2010 · 3,217 citations
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Nature · 2005 · 2,870 citations
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
New England Journal of Medicine · 2020 · 2,437 citations
19 papers
15 papers
15 papers · 3 as a fellow
14 papers
13 papers
- DW
10 papers
9 papers
- IG
8 papers
Grants
- 2026–2031
- 1997–2030
Development of Novel Therapeutic Strategies in Human Leukemias
National Cancer Institute · P01
Project lead · $4.2M · Dana-Farber Cancer Inst
- 1997–2026
Dana-Farber/Harvard Cancer Center
National Cancer Institute · P30
Project lead · $83.4K · Dana-Farber Cancer Inst
- 2016–2026
Comprehensive Dissection of the CLL Genome & Phenome to Improve Patient Outcomes
National Cancer Institute · P01
Project lead · $3.1M · Dana-Farber Cancer Inst